In adults with active dermatomyositis, IV immune globulin improved treatment response at 16 wk vs. placebo
- PMID: 36745896
- DOI: 10.7326/J22-0111
In adults with active dermatomyositis, IV immune globulin improved treatment response at 16 wk vs. placebo
Abstract
Aggarwal R, Charles-Schoeman C, Schessl J, et al. Trial of intravenous immune globulin in dermatomyositis. N Engl J Med. 2022;387:1264-78. 36198179.
Comment on
-
Trial of Intravenous Immune Globulin in Dermatomyositis.N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources